Δομή Προγράμματος

Section: A – Compulsory Courses
Min. ECTS Credits: 70  Max. ECTS Credits: 70

• Drug Development and Ethical Considerations in Pharma Industry (10 ECTS)
• The EU Regulatory Affairs System (10 ECTS)
• Regulatory Strategy and Marketing Applications for New Medicinal Products (10 ECTS)
• Quality Assurance and Compliance (10 ECTS)
• Clinical Trials, Preclinical and Clinical Development and Documentation (10 ECTS)
• Pharmacovigilance and Pharmacoepidemiology (10 ECTS)
• Research Methodology (PHAR-621) (10 ECTS)

Section: B – Elective Courses
Min. ECTS Credits: 20  Max. ECTS Credits: 20
Notes: THESIS Option: PHAR-621 and PHAR-622, NON-THESIS Option: PHAR-621 and 2 Elective Courses

• Master Thesis (PHAR-622) (20 ECTS)
• Regulation of Medical Devices (10 ECTS)
• Market Pricing and Reimbursement (10 ECTS)
• Health Technology Assessment (10 ECTS)
• Product’s Life Cycle Activities (10 ECTS)
• International Regulatory Harmonization (10 ECTS)

Section: C – Unallocated Courses
Min. ECTS Credits: 0 Max. ECTS Credits: 0